SYNDROME OF BURNED SKIN IMPROVEMENTS IN TREATMENT AND DIAGNOSIS
DOI:
https://doi.org/10.62019/1m2e2108Keywords:
infection with Staphylococcus aureus, staphylococcal scalded skin syndrome, staphylococcal toxic shock syndromeAbstract
Background: Staphylococcus aureus produces epidermolytic toxins that disrupt epidermal cell connections, resulting in staphylococcal scalded skin syndrome (SSSS). Blisters, erythematous cellulitis, and superficial skin peeling characterize this condition.
Objective: To provide an overview of the clinical foundation, etiopathogenesis, complications, current treatment options, and potential future advancements in managing SSSS.
Methods: This review synthesizes available data on the pathogenesis, clinical manifestations, differential diagnoses, and therapeutic interventions for SSSS.
Results: It is classified as a toxin-mediated infection, primarily affecting adults and pediatric patients. Key therapeutic interventions include:
- Wound care to protect damaged skin.
- Antibiotic therapy with antistaphylococcal medications.
- Supportive care with analgesia.
Differential diagnoses such as toxic epidermal necrolysis, adverse drug reactions, and Stevens-Johnson syndrome require multidisciplinary evaluation by dermatologists, infectious disease specialists, and surgeons.
Conclusion: Effective management of SSSS involves a multidisciplinary approach to reduce mortality. Future developments may enhance understanding and treatment outcomes for this toxin-mediated disease.
